The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.
作者信息
Messent M, Griffiths M J
机构信息
Department of Anaesthetics and Intensive Care, Royal Brompton and National Heart and Lung Hospital, London.
出版信息
Thorax. 1992 Aug;47(8):651-6. doi: 10.1136/thx.47.8.651.
Abstract
摘要
相似文献
1
The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.肺科医生与重症监护。3. 肺损伤的药物治疗。
Thorax. 1992 Aug;47(8):651-6. doi: 10.1136/thx.47.8.651.
2
3
Pharmacologic treatment of the adult respiratory distress syndrome.成人呼吸窘迫综合征的药物治疗
Clin Chest Med. 1990 Dec;11(4):773-87.
4
Steroid use in acute lung injury/acute respiratory distress syndrome: what about the acute lung injury from H1N1?在急性肺损伤/急性呼吸窘迫综合征中使用类固醇：甲型H1N1流感所致的急性肺损伤情况如何？
Crit Care Med. 2009 Nov;37(11):2996. doi: 10.1097/CCM.0b013e3181b4a049.
5
Corticosteroids: the "terminator" of all untreatable serious pulmonary illness.皮质类固醇：所有无法治疗的严重肺部疾病的“终结者”。
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1409-10. doi: 10.1164/rccm.2310004.
6
7
Corticosteroids in acute lung injury and acute respiratory distress syndrome.急性肺损伤和急性呼吸窘迫综合征中的皮质类固醇
Crit Care Med. 2009 Sep;37(9):2680-1; author reply 2681. doi: 10.1097/CCM.0b013e3181aff6fb.
8
Pharmacology of acute lung injury.急性肺损伤的药理学
Pulm Pharmacol Ther. 2002;15(2):83-95. doi: 10.1006/pupt.2001.0325.
9
Supportive pharmacotherapy for patients with acute respiratory distress syndrome.急性呼吸窘迫综合征患者的支持性药物治疗
Acta Anaesthesiol Scand Suppl. 1996;109:65-9.
10
Lisofylline: anti-acute respiratory distress syndrome or just anti-inflammatory?
Crit Care Med. 2002 Jan;30(1):246-7. doi: 10.1097/00003246-200201000-00037.
本文引用的文献
1
Role of prostaglandins in acute pulmonary microvascular injury.
Ann N Y Acad Sci. 1982;384:517-34. doi: 10.1111/j.1749-6632.1982.tb21397.x.
2
Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome.成人呼吸窘迫综合征患者肺灌洗液中的弹性蛋白酶活性。
N Engl J Med. 1981 Jan 22;304(4):192-6. doi: 10.1056/NEJM198101223040402.
3
Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.呼吸衰竭中肺表面活性物质异常的证据。支气管肺泡灌洗磷脂、表面活性、磷脂酶活性及血浆肌醇的研究。
J Clin Invest. 1982 Sep;70(3):673-83. doi: 10.1172/jci110662.
4
Adult respiratory distress syndrome: risk with common predispositions.成人呼吸窘迫综合征：常见易患因素的风险
Ann Intern Med. 1983 May;98(5 Pt 1):593-7. doi: 10.7326/0003-4819-98-5-593.
5
Experimental and clinical results in shock lung treatment with vitamin E.维生素E治疗休克肺的实验与临床结果
Ann N Y Acad Sci. 1982;393:392-410. doi: 10.1111/j.1749-6632.1982.tb31278.x.
6
Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.成人呼吸窘迫综合征的发病机制。支气管肺泡灌洗液中氧化活性的证据。
J Clin Invest. 1983 Mar;71(3):754-61. doi: 10.1172/jci110823.
7
Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution.血小板活化因子可升高气道和血管压力，并在灌注无血小板溶液的肺中诱发水肿。
Am Rev Respir Dis. 1984 May;129(5):742-6. doi: 10.1164/arrd.1984.129.5.742.
8
Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen.布洛芬对人多形核白细胞细胞反应的抑制作用。
J Pharm Sci. 1984 Oct;73(10):1403-6. doi: 10.1002/jps.2600731020.
9
Actions of lipoxygenase metabolites in isolated rat lungs.脂氧合酶代谢产物在离体大鼠肺中的作用。
J Appl Physiol Respir Environ Exerc Physiol. 1984 Sep;57(3):860-7. doi: 10.1152/jappl.1984.57.3.860.
10
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.补体激活及血浆C5a升高与成人呼吸窘迫综合征的关联。病理生理相关性及可能的预后价值。
Lancet. 1980 May 3;1(8175):947-9. doi: 10.1016/s0140-6736(80)91403-8.
Zotero 插件